Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-26 @ 1:30 PM
Study NCT ID:
NCT04294667
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2020-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-04
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-27
First Submit QC Date:
None
Study First Post Date:
2020-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-03
Results First Submit QC Date:
None
Results First Post Date:
2025-04-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-30
Last Update Post Date:
2025-05-04
Last Update Post Date Type:
ACTUAL